Abstract
The increase in detection of alprazolam among cases of HRD, particularly since 2005, and the disproportionate increase in prescribing of the high-dose 2 mg formulation compared with other formulations suggest a need to examine alprazolam prescribing and to identify inappropriate prescribing and the circumstances of diversion from licit to illicit use.
Original language | English |
---|---|
Pages (from-to) | 206 - 209 |
Number of pages | 4 |
Journal | The Medical Journal of Australia |
Volume | 198 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2013 |